Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

MIND-FULNESS-BASED FAMILY RESILIENCE INTERVENTION FOR MOTHERS OF CHILDREN WITH INTELLECTUAL DISABILITIES

6 settembre 2026 aggiornato da: Filiz ER, Sinop University

STRENGTHENING FAMILY RESILIENCE THROUGH MINDFULNESS: A RANDOMIZED CONTROLLED MIXED-METHODS GROUP INTERVENTION WITH MOTHERS OF CHILDREN WITH INTELLECTUAL DISABILITIES

The goal of this clinical trial is to learn whether an eight-week Mindfulness-Based Family Resilience Group Intervention can improve family resilience and mindfulness in mothers of children with intellectual disabilities. The intervention combines mindfulness practices with principles from Walsh's systemic family resilience model.

The main questions it aims to answer are:

  • Does the intervention improve mothers' reported family resilience?
  • Does the intervention improve mothers' mindfulness?
  • How do mothers describe their caregiving experiences, parenting roles, and family life, and how do these experiences change during the intervention?

Researchers will compare mothers who receive the Mindfulness-Based Family Resilience Group Intervention with mothers in a control group who continue to receive usual care.

Participants in the intervention group will:

  • Attend one group session per week for eight weeks, with each session lasting approximately 90 minutes.
  • Take part in mindfulness practices and activities focused on awareness of thoughts, emotions, and bodily experiences, acceptance, self-compassion, and personal and family resources.
  • Complete assessments of family resilience and mindfulness before the intervention, after the intervention, and at a three-month follow-up.

Participants in the control group will continue to receive usual care and will complete the same assessments at the same time points.

The study will also examine participants' experiences during the group intervention to better understand the processes that accompany changes in family resilience and mindfulness.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Mothers of children with intellectual disabilities may experience long-term caregiving demands that affect their emotional well-being, coping processes, and family life. Family resilience provides a systemic framework for understanding how families adapt to ongoing challenges by drawing on shared belief systems, organizational resources, communication, and problem-solving processes. Mindfulness, in turn, emphasizes present-moment awareness and a nonjudgmental approach to thoughts, emotions, and bodily experiences. Integrating these two approaches may provide a way to support both individual awareness and family-related coping resources.

The Mindfulness-Based Family Resilience Group Intervention was developed by integrating Walsh's systemic family resilience framework with core mindfulness principles and practices. The program was designed to help mothers become more aware of their thoughts, emotions, and bodily responses; relate to difficult experiences with greater acceptance and self-compassion; recognize automatic patterns of responding; and identify personal and family strengths and resources. Family resilience processes, including meaning-making, organizational patterns, communication, and problem solving, were addressed alongside mindfulness-based experiential practices.

The intervention consisted of eight weekly group sessions, each lasting approximately 90 minutes. Across the program, participants engaged in practices involving breath and body awareness, present-moment attention, nonjudgmental observation of thoughts and emotions, acceptance, self-compassion, emotion regulation, and reflection on personal and family resources. Experiential exercises and group discussions were used to connect mindfulness practices with participants' caregiving experiences, parenting roles, and family relationships.

The study used a randomized controlled, embedded mixed-methods design. The quantitative component was designed to evaluate changes in family resilience and mindfulness over time and to compare these changes between the intervention and usual-care control conditions. The qualitative component was embedded within the intervention process to provide a more detailed understanding of participants' experiences and the processes accompanying change.

Qualitative information obtained from group-session recordings and field notes was examined using thematic analysis. This component focused on how participants described and made sense of their caregiving experiences, difficult thoughts and emotions, parenting roles, personal and family resources, and changes experienced during the intervention. Integrating the quantitative and qualitative components was intended to provide a broader understanding of both changes in the measured outcomes and the experiential processes accompanying those changes.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

32

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Descrizione

Inclusion Criteria:

  • * Mothers of children aged 9-17 years.

    • Mothers whose children had mild or moderate intellectual disability.
    • Willingness to participate in the study and provide informed consent.

Exclusion Criteria:

  • Mothers whose children had severe intellectual disability.
  • Not meeting the predefined inclusion criteria.
  • Declining to participate in the study.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Quadruplicare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Change in Family Resilience and Change in Mindfulness
Participants assigned to the experimental arm received the eight-week Mindfulness-Based Family Resilience Group Intervention. The intervention was delivered once weekly, with each group session lasting approximately 90 minutes. The program integrated Walsh's systemic family resilience framework with mindfulness-based practices, including breath and body awareness, nonjudgmental observation of thoughts and emotions, acceptance, self-compassion, emotion regulation, and activities aimed at identifying personal and family resources.
The Mindfulness-Based Family Resilience Group Intervention was an eight-week, group-based behavioral intervention integrating mindfulness practices with Walsh's systemic family resilience framework. The intervention was delivered once weekly, with each session lasting approximately 90 minutes. The eight sessions focused sequentially on: (1) building safety and awareness, (2) acceptance of emotions and self-compassion, (3) values and meaning-making, (4) acceptance of uncertainty, (5) flexible problem solving, (6) discovering family strengths, (7) consolidating gains and relapse prevention, and (8) integration and closure. Core mindfulness components included breath and body awareness, acceptance-based mindfulness, values-focused mindfulness, cognitive defusion and observing thoughts, strength-focused mindfulness, the three-minute breathing space, and compassion and gratitude meditation. Experiential and group activities were used to support emotional awareness, acceptance, psychological
Nessun intervento: Control Group
Participants assigned to the control group continued to receive usual care during the study period and did not receive the Mindfulness-Based Family Resilience Group Intervention. They completed the same outcome assessments as the experimental group at baseline, post-intervention, and the three-month follow-up.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Family Resilience Scale (FRS)
Lasso di tempo: Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)
Family resilience was assessed using the Family Resilience Scale (FRS), developed by Kaner and Bayraklı (2010). The scale consists of 37 items rated on a 5-point Likert scale ranging from 1 ("Does not describe me at all") to 5 ("Describes me very well"). Total scores range from 37 to 185, with higher scores indicating higher levels of family resilience. The scale includes four subscales: Resilience/Challenge (17 items), Self-Efficacy (9 items), Commitment to Life (8 items), and Control (3 items).
Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)
Mindful Attention Awareness Scale (MAAS)
Lasso di tempo: Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)
Mindfulness was assessed using the Mindful Attention Awareness Scale (MAAS), developed by Brown and Ryan (2003). The scale consists of 15 items rated on a 6-point Likert scale ranging from 1 ("Almost always") to 6 ("Almost never"). Total scores range from 15 to 90, with higher scores indicating higher levels of mindful attention and awareness. The Turkish adaptation, validity, and reliability study of the scale was conducted by Özyeşil et al. (2011).
Baseline (March 13, 2026), immediately post-intervention (May 1, 2026), and 3-month follow-up (July 31, 2026)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

13 marzo 2026

Completamento primario (Effettivo)

1 maggio 2026

Completamento dello studio (Effettivo)

21 luglio 2026

Date di iscrizione allo studio

Primo inviato

6 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

6 settembre 2026

Primo Inserito (Effettivo)

14 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

14 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

6 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 2025/613

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be made publicly available because of participant confidentiality and privacy considerations. The study included a relatively small sample and qualitative data derived from group-session recordings and field notes, which may increase the risk of participant identification even after de-identification. In addition, specific consent for public sharing of individual participant data was not obtained from participants. Aggregate study findings will be reported in scientific publications.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .